Thomas R. Broker

10.4k citations

71 papers · 7.5k indexed · 3 hit papers · h-index 41

Epidemiology top 0.5%
Molecular Biology top 2%
Genetics top 0.5%
Oncology top 2%
Surgery top 5%

Co-authors: Louise T. Chow Ethel-Michele de Villiers Claude Fauquet Harald zur Hausen Hans-Ulrich Bernard James B. Lewis Richard J. Roberts Richard Gelinas
Topics: Cervical Cancer and HPV Research (32 papers)Virus-based gene therapy research (21 papers)Cancer-related Molecular Pathways (11 papers)
Cited by: Epidemiology Genetics Microbiology
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Netherlands Germany

In The Last Decade

Thomas R. Broker

69 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification of papillomaviruses

2004 2.4k citations Ethel-Michele de Villiers, Claude Fauquet et al. Virology profile →
An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA

1977 857 citations Louise T. Chow, Thomas R. Broker et al. profile →
Complex splicing patterns of RNAs from the early regions of adenovirus-2

1979 500 citations Louise T. Chow, Thomas R. Broker et al. profile →

Peers

Countries citing papers authored by Thomas R. Broker

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Broker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Broker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Broker more than expected).

Fields of papers citing papers by Thomas R. Broker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Broker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Broker. The network helps show where Thomas R. Broker may publish in the future.

Co-authorship network of co-authors of Thomas R. Broker

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Broker. A scholar is included among the top collaborators of Thomas R. Broker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Broker. Thomas R. Broker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic diversity and phylogenetic relationships of human papillomavirus 16 (HPV16) in Nepal 2016 ·Infection Genetics and Evolution ·Robert Makowsky,Pema Lhaki,Howard W. Wiener,Madhav P. Bhatta,Michael Cullen,Derek C. Johnson,Rodney T. Perry,(unknown),Joseph F. Boland,Meredith Yeager,(unknown),Thomas R. Broker,Sadeep Shrestha	7
2	536 In vitro and in vivo efficacy of nitric oxide-releasing antiviral therapeutic agents 2016 ·Journal of Investigative Dermatology ·(unknown),Karla K. Balogh,H. Wang,(unknown),(unknown),(unknown),Thomas R. Broker,Nathan Stasko	2
3	Therapy of Human Papillomavirus-Related Disease 2012 ·Vaccine ·Peter L. Stern,Sjoerd H. van der Burg,Ian Hampson,Thomas R. Broker,Alison Fiander,Charles Lacey,Henry C Kitchener,Mark H. Einstein	120
4	Human Papillomavirus and Cancer Prevention: Gaps in Knowledge and Prospects for Research, Policy, and Advocacy 2012 ·Vaccine ·Eduardo L. Franco,Silvia de Sanjosé,Thomas R. Broker,Margaret Stanley,Myriam Chévarie‐Davis,Sandra D. Isidean,Mark Schiffman	33
5	Anal-Rectal Cytology 2010 ·Journal of Lower Genital Tract Disease ·Sarah M. Bean,David C. Chhieng,Janie Roberson,James L. Raper,Thomas R. Broker,Craig Hoesley,Isam A. Eltoum,Ge Jin	18
6	Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6 2009 ·RNA ·Xiaohong Wang,Hsu-Kun Wang,J. Philip McCoy,N. Sanjib Banerjee,Janet S. Rader,Thomas R. Broker,Craig Meyers,Louise T. Chow,Zhi‐Ming Zheng	195
7	Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds 2007 ·Journal of Molecular Medicine ·Alexander Stoff,Ángel A. Rivera,J. Michael Mathis,Steven T. Moore,N. Sanjib Banerjee,Maaike Everts,A. Espinosa de los Monteros,Zdeněk Novák,Luis O. Vásconez,Thomas R. Broker,Dirk F. Richter,Dale S. Feldman,Gene P. Siegal,Mariam A. Stoff‐Khalili,David T. Curiel	42
8	Strategies to enhance transductional efficiency of adenoviral‐based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds 2006 ·Wound Repair and Regeneration ·Alexander Stoff,Ángel A. Rivera,N. Sanjib Banerjee,J. Michael Mathis,A. Espinosa de los Monteros,Long P. Le,Jorge I. de la Torre,Luis O. Vásconez,Thomas R. Broker,Dirk F. Richter,Mariam A. Stoff‐Khalili,David T. Curiel	15
9	The human homolog of drosophila disc large protein (hDLG) is antigenic and a potential tumor suppressor in melanoma 2004 ·Cancer Research ·(unknown),(unknown),(unknown),N. Sanjib Banerjee,Thomas R. Broker,Theresa V. Strong	1
10	Classification of papillomavirusesbreakdown → 2004 ·Virology ·Ethel-Michele de Villiers,Claude Fauquet,Thomas R. Broker,Hans-Ulrich Bernard,Harald zur Hausen	2360
11	Immune responses to human papillomavirus in genital tract of women with cervical cancer 2004 ·Gynecologic Oncology ·Huan Huu Nguyen,Thomas R. Broker,Louise T. Chow,Ronald D. Alvarez,Huong Vu,(unknown),(unknown),Ge Jin,Jiří Městecký	51
12	Recurrent Respiratory Papillomatosis: A Longitudinal Study Comparing Severity Associated With Human Papilloma Viral Types 6 and 11 and Other Risk Factors in a Large Pediatric Population 2004 ·The Laryngoscope ·Brian J. Wiatrak,(unknown),Thomas R. Broker,Linda S. Lewis	210
13	Identification of Alternatively Spliced mRNAs and Localization of 5' Ends by Polymerase Chain Reaction Amplification 2003 ·Humana Press eBooks ·Cheng-Ming Chiang,Louise T. Chow,Thomas R. Broker	3
14	HeLa Cells Are Phenotypically Limiting in Cyclin E/CDK2 for Efficient Human Papillomavirus DNA Replication 2000 ·Journal of Biological Chemistry ·Biing Yuan Lin,Tianlin Ma,Jen‐Sing Liu,Shu‐Ru Kuo,Ge Jin,Thomas R. Broker,J. Wade Harper,Louise T. Chow	38
15	A Distal Element in the HPV-11 Upstream Regulatory Region Contributes to Promoter Repression in Basal Keratinocytes in Squamous Epithelium 1999 ·Virology ·Wei Zhao,Louise T. Chow,Thomas R. Broker	16
16	Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes 1998 ·Oncogene ·(unknown),(unknown),Wei‐Ming Chien,Xing Wu,Thomas R. Broker,Louise T. Chow	57
17	In vitro experimental systems for HPV: Epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences 1997 ·Clinics in Dermatology ·Louise T. Chow,Thomas R. Broker	49
18	CD45 up-regulation during lymphocyte maturation 1996 ·International Immunology ·Jörg Kirberg,Thomas R. Broker	13
19	Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. 1996 ·PubMed ·Renske D.M. Steenbergen,J. M. M. Walboomers,Chris J.L.M. Meijer,(unknown),Jonathan Parker,Louise T. Chow,Thomas R. Broker,Peter J.F. Snijders	111
20	Papillomavirus-associated inductions of cellular proteins in mouse C127 cells: Correlation with the presence of open reading frame E2 1989 ·Virology ·Richard M. Levenson,Ute Brinckmann,M. Kerry O’Banion,Elliot J. Androphy,(unknown),(unknown),Lubomír P. Turek,(unknown),Michael T. Chin,Thomas R. Broker,Louise T. Chow,(unknown)	4

About Thomas R. Broker

Thomas R. Broker is a scholar working on Epidemiology, Genetics and Immunology, having authored 71 papers that have together received 7.5k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (32 papers), Virus-based gene therapy research (21 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Epidemiology (3.9k citations), Genetics (2.1k citations) and Microbiology (450 citations). Thomas R. Broker has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Louise T. Chow, Ethel-Michele de Villiers, Claude Fauquet, Harald zur Hausen, Hans-Ulrich Bernard, James B. Lewis, Richard J. Roberts, Richard Gelinas, I Lehman and Mohammad Nasseri. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact